Procter & Gamble Hygiene & Healthcare Ltd.

- Resear
(Rs crore)
Balance sheet
Jun ' 09 Jun ' 08 Jun ' 07 Jun ' 06 Jun ' 05
Sources of funds
Owner's fund
Equity
share
capital 32.46 32.46 32.46 32.46 32.46
Share
applicati
on
money - - - - -
Preferenc
e share
capital - - - - -
Reserves
&
surplus 407.58 314.18 258.72 240.2 193.22
Loan funds
Secured
loans - - - - -
Unsecure
d loans - - - - -
Total 440.04 346.64 291.18 272.66 225.68
Uses of funds
Fixed assets
Gross
block 221.82 203.09 163.62 127.01 178.76
Less :
revaluati
on
reserve - - - - -

Less :
accumula
ted
depreciat
ion 89.54 80.01 69.61 61.64 99.69
Net
block 132.29 123.08 94.01 65.38 79.07
Capital
work-in-
progress 24.51 12.88 33.47 29.18 9.96
Investme
nts - - - - 0.01
Net current assets
Current
assets,
loans &
advances 501.18 435.29 335.97 353.59 407.74

Less :
current
liabilities
&
provision
s 217.94 224.61 172.27 175.49 271.09
Total net
current
assets 283.24 210.68 163.7 178.1 136.64

Miscella
neous
expenses
not
written - - - - -
Total 440.04 346.64 291.18 272.66 225.68
Notes:
Book
value of
unquoted
investme
nts - - - - 0.01

Market
value of
quoted
investme
nts - - - - -
Continge
nt
liabilities 55.06 25.55 98.56 136.22 51.87
 Number
of equity
sharesout
standing
(Lacs) 324.61 324.61 324.61 324.61 324.61
(Rs crore)
Profit loss account
Jun ' 09 Jun ' 08 Jun ' 07 Jun ' 06 Jun ' 05

Income
Operatin
g income 772.81 643.95 537.58 565.77 682
Expens
es
Material
consume
d 235.58 177.59 150.74 195.93 320.71
Manufact
uring
expenses
  74.15 72.33 64.49 74.53 67.19
Personne
l
expenses 59.21 54.65 37.72 33.99 37.37
Selling
expenses 181.3 131.84 127.65 108.44 92.73
Adminstr
ative
expenses 8.07 28.83 18.49 23.89 30.17
Expenses
capitalise
d - - - - -
Cost of
sales 558.31 465.24 399.08 436.77 548.18
Operatin
g profit 214.5 178.7 138.5 129 133.82
Other
recurring
income 26.94 16.69 16.43 19.98 18.98
Adjusted
PBDIT 241.44 195.39 154.93 148.98 152.81
Financial
expenses - 0.02 0.01 0.11 0.05
Deprecia
tion 
Other 14.37 12.12 8.98 7.92 12.4
write
offs - - - - -
Adjusted
PBT 227.07 183.24 145.94 140.95 140.36
Tax
charges  52.81 49.15 44.96 53.83 48.42
Adjusted
PAT 174.26 134.09 100.98 87.12 91.94
Non
recurring
items -7.2 -3.16 -0.44 8.03 6.88
Other
non cash
adjustme
nts 11.79 0.48 -10.72 44.36 25.79
Reported
net profit 178.85 131.42 89.82 139.51 124.61
Earnigs
before
appropria
tion 304.82 215.08 168.62 185.29 206.3
Equity
dividend 73.04 64.92 64.92 81.15 129.84
Preferenc
e
dividend - - - - -
Dividend
tax 12.41 11.03 11.03 11.38 18.21
Retained
earnings 219.37 139.13 92.67 92.76 58.25

Cash flow
Jun ' 09 Jun ' 08 Jun ' 07 Jun ' 06 Jun ' 05
Profit
before tax 231.66 180.57 145.5 193.34 177.79

Net
cashflow-
operating
activity 165.57 132.16 71.29 141.55 76.74

Net cash
used in
investing
activity -167.6 78.6 -190.36 20.99 -4.19

Netcash
used in
fin.
activity -75.96 -75.98 -92.54 -148.16 -73.46

Net
inc/dec in
cash and
equivlnt -77.99 134.79 -211.62 14.38 -0.91

Cash and
equivalnt
begin of
year 165.96 31.18 242.79 228.42 229.33

Cash and
equivalnt
end of
year 87.97 165.96 31.18 242.79 228.42
Ltd. - Research Center